Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	19,705	9,568	3,575	514	95	70
Market Cap Growth	185.17%	167.65%	595.01%	443.89%	35.73%	-4.81%
Enterprise Value	19,609	9,415	3,504	520	199	165
Last Close Price	45.00	21.84	8.03	1.15	0.31	0.23
PE Ratio	237.21	99.92	19.28	11.67	12.60	37.04
PS Ratio	54.42	29.36	4.79	0.87	0.46	0.62
PB Ratio	29.94	15.23	6.20	2.03	0.58	0.45
P/TBV Ratio	29.94	15.23	6.20	2.03	0.58	0.45
P/FCF Ratio	-	184.87	-	-	1.47	-
P/OCF Ratio	-	120.83	-	16.23	1.18	12.97
EV/Sales Ratio	54.15	28.89	4.70	0.88	0.97	1.47
EV/EBITDA Ratio	122.78	60.91	16.18	8.01	6.78	9.38
EV/EBIT Ratio	154.01	75.61	17.87	11.17	15.63	58.82
EV/FCF Ratio	-360.89	181.91	-	-	3.09	-
Debt / Equity Ratio	0.06	0.07	0.06	0.20	0.21	0.63
Debt / EBITDA Ratio	0.24	0.27	0.15	0.78	1.15	5.57
Debt / FCF Ratio	-	0.81	-	-	0.52	-
Asset Turnover	0.43	0.40	0.98	1.08	0.58	0.32
Inventory Turnover	0.85	1.35	16.28	12.78	3.73	1.81
Quick Ratio	1.01	2.33	2.89	1.00	0.62	1.46
Current Ratio	3.80	3.79	3.97	1.25	1.28	2.28
Return on Equity (ROE)	19.92%	15.90%	44.70%	21.16%	4.70%	1.21%
Return on Assets (ROA)	9.48%	9.46%	16.04%	5.29%	2.25%	0.51%
Return on Invested Capital (ROIC)	20.71%	16.91%	47.35%	20.16%	4.24%	1.16%
Return on Capital Employed (ROCE)	18.20%	17.90%	30.80%	14.40%	5.60%	1.00%
Earnings Yield	0.61%	1.00%	5.19%	8.57%	7.94%	2.70%
FCF Yield	-0.28%	0.54%	-1.95%	-2.57%	68.08%	-18.00%
Dividend Yield	0.02%	0.05%	1.24%	1.09%	4.06%	-
Payout Ratio	3.66%	45.73%	0.38%	1.65%	-	-
Buyback Yield / Dilution	-53.87%	-	-551.03%	-7.38%	-	-0.02%
Total Shareholder Return	-53.85%	0.05%	-549.78%	-6.29%	4.06%	-0.02%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.